buy microsoft office enterprise 2007

buy Microsoft Office 2003 Professional sp3buy autodesk autocad 2009
Privacy Policy User Agreement Contact Us
  Extended Search

Current Issue
Archives
Contributors
Submission Guidelines
Important Research
ND Calendar
ND Update
Nutrition and Herbs
ND Locator
Reader Poll
Schools & Associations
Consumer Information
Contact Us
Link To Us
Site Map
 

Inside the Profession

University of Bridgeport College of Naturopathic Medicine Awarded CNME Accreditation

BRIDGEPORT, Conn. - In March, the Council on Naturopathic Medical Education (CNME) granted the University of Bridgeport's College of Naturopathic Medicine degree program accreditation for a three-year period - the fourth U.S. naturopathic program to be awarded full CNME accreditation, and the youngest such program in the nation (the first class entered in the fall of 1997).

The college was awarded candidacy status in April 2001, and has worked toward achieving full accreditation for the past five years. Either candidacy or accreditation is required for graduates of naturopathic programs to be eligible to sit for the NPLEX, which is required by most states (such as Connecticut) that license naturopathic physicians.

"Accreditation assures the public, prospective students and other institutions that the college meets appropriate standards for program of study, faculty, fiscal and physical resources, student services, research and learning resources," said Univ. of Bridgeport President, Neil Albert Salonen.

"The college takes its place beside the other accredited colleges in the United States and Canada. That puts the college in a stronger position to attract applicants and resources, helps with fundraising and attracting research support and the development of collaborative efforts with other institutions of higher learning," added Dean G.S.S. Khalsa.

To learn more about the University of Bridgeport's naturopathic degree program, visit www.bridgeport.edu. For more information about accredited/candidate naturopathic programs in the U.S. and Canada, read "New Kid on the Naturopathic Block" on the front page of this issue.


California Naturopathic Doctors Elect New Association President

Dr. Gina Nick was recently elected president of the California Naturopathic Doctors Association (CNDA) by the association's board of directors. Dr. Nick will guide the CNDA's continuing efforts to establish licensed naturopathic doctors as California's natural medicine experts. Her hope is to position the CNDA as the source for expert information on the clinical use of natural medicine, while securing revenue sources through mutually advantageous relationships with companies and organizations that support the association's legislative, professional and fundraising goals.

"I am thrilled and honored to be the guiding force behind the CNDA," said Dr. Nick. "I have a highly skilled and motivated board of directors to work with and see that licensed naturopathic doctors in the state of California are poised to reach new levels of growth and success over the coming year."


Southwest Research Team Studying Effects of Heavy Metals on Autism

Researchers at Southwest College of Naturopathic Medicine (SCNM) will be investigating heavy metal toxicity and pediatric autism in an upcoming chelation study titled "DMSA Treatment of Children with Autism and Heavy Metal Toxicity." Matthew Baral, ND, assistant professor of pediatric medicine at SCNM, is leading the study. The research team also includes James B. Adams, PhD, adjunct professor in the Division of Basic Medical Sciences at SCNM; Walter Crinnion, ND, director of the SCNM Environmental Medicine Center of Excellence; and Sanford Newmark, MD, from the Center for Pediatric Integrative Medicine in Tucson, Ariz. The team began enrolling participants in this two-part research study in October 2005.

The study will be conducted in two phases: In Phase I, participants will receive 2, 3-dimercaptosuccinic acid (DMSA) and be evaluated for presence of toxic heavy metals. Participants with heavy metals will receive DMSA or a placebo in Phase II, a double-blind, placebo controlled trial. DMSA is a FDA-approved medication for treating lead poisoning. Some of the participants also will receive the antioxidant glutathione. The study is sponsored by the Wallace Foundation and will be conducted at Southwest.

The participant pool for the study is limited to Arizona residents ages 3-8 and diagnosed with autism spectrum disorder. For more information, contact Dr. Baral at m.baral@scnm.edu or Dr. Adams at j.adams@scnm.edu.

Written by Julie Engebretson

 



Archives | Contributors | Current Issue
Important Research | Naturopathy Calendar | ND Online | Nutrition & Herbs
ND Locator | Reader Poll | Schools & Associations | Submission Guidelines
Consumer Information | Contact Us | Link To Us | Site Map

Other MPA Media Sites:
ChiroWeb | AcupunctureToday | MassageToday | DynamicChiropractic | DynamicChiropractic Canada
ChiroFind | ToYourHealth | ChiropracticResearchReview | NutritionalWellness | SpaTherapy

Policies:
User Agreement | Privacy Policy

All Rights Reserved, Naturopathy Digest, 2011.
Date Last Modified - Friday, 17-Oct-2008 12:10:47 PDT